October 9th, 2026How Do Long-Term MAIA and CEPHEUS Data Reinforce Daratumumab Use in NDMM?Experts in multiple myeloma discussed long-term MAIA and CEPHEUS trial data and their implications for daratumumab-based regimens in newly diagnosed disease.Read more